Key clinical point: Methotrexate, in combination with prednisone, might be emerging as the go-to option for idiopathic granulomatous mastitis.
Major finding: Reported remission rates range from 75%-100%.
Study details: A single-center review of 23 patients
Disclosures: There was no external funding, and the investigators didn’t report any disclosures.
Ringsted S et al. Arthritis Rheumatol. 2019;71(suppl 10), Abstract 386.